Tarsus Pharmaceuticals Inc (TARS) Insider Trading
- $8,575,268.80
- $36,845,179.82
- March 19, 2026
- Bobak R Azamian
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 2, 2022 | Major Shareholder | 41,800 | $15.19 | Sell | $634,942.00 | |
| Dec. 1, 2021 | Director | 5,833 | $24.68 | Sell | $143,958.44 | |
| Nov. 8, 2021 | Insider | 1,889 | $28.11 | Sell | $53,099.79 | |
| Nov. 4, 2021 | Insider | 100 | $28.03 | Sell | $2,803.00 | |
| Nov. 2, 2021 | Insider | 6,000 | $26.78 | Sell | $160,680.00 | |
| Nov. 1, 2021 | Director | 5,833 | $27.82 | Sell | $162,274.06 | |
| Oct. 12, 2021 | CEO | 5,531 | $26.30 | Sell | $145,465.30 | |
| Oct. 12, 2021 | Director | 5,633 | $26.27 | Sell | $147,978.91 | |
| Oct. 8, 2021 | Director | 200 | $25.03 | Sell | $5,006.00 | |
| Oct. 8, 2021 | CEO | 302 | $25.02 | Sell | $7,556.04 | |
| Sept. 10, 2021 | Insider | 2,593 | $22.15 | Sell | $57,434.95 | |
| Sept. 1, 2021 | Director | 5,833 | $25.24 | Sell | $147,224.92 | |
| Aug. 11, 2021 | Director | 621 | $25.15 | Sell | $15,618.15 | |
| Aug. 11, 2021 | CEO | 1,917 | $25.07 | Sell | $48,059.19 | |
| Aug. 9, 2021 | Director | 700 | $25.00 | Sell | $17,500.00 | |
| Aug. 9, 2021 | CEO | 827 | $25.02 | Sell | $20,691.54 | |
| Aug. 6, 2021 | Director | 3,129 | $25.00 | Sell | $78,225.00 | |
| Aug. 5, 2021 | CEO | 1,370 | $25.00 | Sell | $34,250.00 | |
| June 25, 2021 | Major Shareholder | 7,704 | $29.60 | Sell | $228,038.40 | |
| June 23, 2021 | Major Shareholder | 37,980 | $29.80 | Sell | $1,131,804.00 | |
| June 21, 2021 | Major Shareholder | 91,620 | $29.70 | Sell | $2,721,114.00 | |
| May 7, 2021 | Major Shareholder | 450,000 | $29.98 | Sell | $13,491,000.00 | |
| April 14, 2021 | Major Shareholder | 400 | $30.37 | Sell | $12,148.00 | |
| Oct. 20, 2020 | Director | 171,875 | $16.00 | Buy | $2,750,000.00 | |
| Oct. 20, 2020 | Major Shareholder | 250,000 | $16.00 | Buy | $4,000,000.00 |
Insiders are both buying and selling Tarsus Pharmaceuticals Inc stock.
The insider traders at Tarsus Pharmaceuticals Inc are: Bobak R Azamian, Bryan Wahl, Aziz Mottiwala, Michael Ackermann, Dianne C Whitfield, Leonard M Greenstein, Vivo Capital Ix, Llc, Elizabeth Yeu Lin, Seshadri Neervannan, Jose M Trevejo, Jeffrey S Farrow, William J Phd Link, Mark J Holdbrook, Rtw Investments, Lp, Jason E Tester, Vivo Capital Fund Ix, L.P., Bobak R. Azamian, and Andrew D Goldberg
The most active insider trader at Tarsus Pharmaceuticals Inc is Bobak R Azamian with 48 trades.
Rtw Investments, Lp has sold the most Tarsus Pharmaceuticals Inc stock with a total value of $26,982,000.00.
Vivo Capital Fund Ix, L.P. has bought the most Tarsus Pharmaceuticals Inc stock with a total value of $8,000,000.00.
The most recent insider trade for Tarsus Pharmaceuticals Inc was on March 19, 2026.
The single biggest insider buy for Tarsus Pharmaceuticals Inc was from Vivo Capital Fund Ix, L.P. with a total value of $4,000,000.00 on Oct. 20, 2020.
The single biggest insider sell for Tarsus Pharmaceuticals Inc was from Rtw Investments, Lp with a total value of $13,491,000.00 on May 7, 2021.